Background: Assessment of health-related quality of life (HRQOL) is important for cost-effectiveness analyses, but the validity of generic HRQOL instruments has not been adequately evaluated in persons with dementia. Objective: To evaluate the validity (including responsiveness to change) of the Health Utilities Index Mark 2 (HUI2) and Mark 3 (HUI3), 2 commonly used generic HRQOL measures, in patients with dementia. Subjects: Four hundred eight patient-caregiver dyads in an 18month dementia care management trial. Methods: We assessed construct validity by evaluating correlations of proxy (caregiver)-reported HUI2 and HUI3 with the Blessed Dementia Rating Scale, the Charlson Comorbidity Index, and a behavior rating scale. Responsiveness was estimated using effect size (ES) statistics for behavior scale change (unchanged, small, medium, large change) and for residential status change (home to skilled nursing facility), as a global external change criterion. Results: The HUI2 and HUI3 were responsive to behavioral worsening (multiattribute ES range: Ϫ0.48 to Ϫ0.78) and global decline (multiattribute ES range: Ϫ0.50 to Ϫ0.76), but not improvement. The HUI2 was more responsive than the HUI3. Correlations with the Blessed Dementia Rating Scale (r ϭ Ϫ0.69 with both HUI2 and HUI3 multiattribute scores) and behavior scale (r ϭ 0.44 and 0.41, respectively, for HUI2 and HUI3 multiattribute scores) supported the validity of the HUI in patients with dementia. Conclusions: Our results support the construct validity of the proxy-rated HUI2/3 in patients with moderate to severe dementia, but responsiveness results were mixed. Further studies are needed of the HUI2/3's validity, including responsiveness, in patients across the full range of dementia severity, using both self and proxy report, with particular attention to the impact of general population preference weights. When possible, multiple HRQOL measures need to be used to confirm the robustness of the findings. The proxy-rated HUI should be used in patients with moderate to severe dementia, but the self-rated HUI may be appropriate for subjects with milder cognitive impairment.
A lzheimer disease (AD) affects 3 to 4 million persons in the United States, at an estimated cost of $100 billion annually, and the prevalence and cost of dementia are projected to rise significantly in the coming decades. 1 To respond optimally to this growing public health problem, health policy makers must have valid assessments of the cost-effectiveness of available interventions for management of AD. Generic preference-based health-related quality of life (HRQOL) instruments, which assign numerical values (utilities) to health states based on preferences expressed in population surveys, are used to measure health benefits of clinical interventions across disease categories. 2 However, since the validity of generic HRQOL instruments in patients with dementia is still uncertain, recent cost-utility studies employing such measures have sparked controversy. 3 The Health Utilities Index (HUI) is a generic, utilitybased HRQOL instrument applied in patients with a wide range of medical conditions in both clinical and general populations internationally. The HUI Mark 2 (HUI2) has 7 attributes, each with 3 to 5 levels: sensation, mobility, emotion, cognition, self-care, pain, and fertility. The HUI Mark 3 (HUI3) has 8 attributes, each with 5 to 6 levels: vision, hearing, speech, ambulation, dexterity, emotion, cognition and pain. Although the HUI3 was designed to address shortcomings of the HUI2, the scales are viewed to be complementary, and scores for both can be generated from the same instrument. 4 There are few published reports on the validity of the HUI in patients with AD and other dementias, and findings are mixed. In 1 cross-sectional comparison of the HUI2 and the HUI3 in patients with AD, scores on proxy-rated versions of both instruments discriminated well across dementia stages (questionable, mild, moderate, severe, profound, and terminal) defined by the Clinical Dementia Rating scale in the expected direction (ie, lower HRQOL in more advanced dementia). The greatest differences in HRQOL by dementia stage were observed in the HUI cognition and HUI2 self-care attributes. 5 In contrast, in a sample of patients with mild to moderate AD, Naglie et al found no significant associations (Spearman correlations) between either patient or proxy-rated HUI3 scores and measures of physical function (Katz Activities of Daily Living, Lawton Instrumental Activities of Daily Living), depressive symptoms (Geriatric Depression Scale), or cognition (Mini Mental State Examination). 6 Evidence of the reliability of the HUI in patients with dementia is limited. Naglie et al found that test-retest reliability (at 2 weeks) of the HUI3 with proxy informants in mild and moderate dementia exceeded the standard for adequate reliability of 0.70 (intraclass correlation coefficient ͓ICC͔ ϭ 0.81). Test-retest reliability was also acceptable for self-rated HUI3 in those with mild dementia (ICC ϭ 0.75), but was poor for those with moderate dementia (ICC ϭ 0.25). 6 The HUI's responsiveness to change in patients with dementia has not been previously reported, yet evaluation of the cost utility of new therapies and of quality improvement interventions requires utility measures that are sensitive to meaningful change. In view of the lack of data and mixed findings on the validity of the HUI in patients with dementia, we conducted an assessment of construct validity (including responsiveness to change) of the HUI2 and the HUI3 in a longitudinal trial of dementia care management. 7
METHODS

Sample
Our analysis is drawn from data on 408 dementia patient-caregiver dyads enrolled in a care management trial, receiving care from one of 3 San Diego health care organizations. All patients identified in the organizations' administrative databases as having an ICD code for dementia 8 for a visit or hospitalization in the prior year, with diagnosis verified by each patient's primary care physician and confirmed through chart review, were eligible for study inclusion, and approximately 43% of eligibles enrolled. 7 At baseline, 12 and 18 months, caregivers were mailed surveys that included study measures. All 408 enrolled dyads had baseline data; follow-up data at 12 and 18 months were available on 82% and 88%, respectively.
Measures HRQOL
Caregivers completed a proxy version of the 15-item HUI, assessing patients' HRQOL over the preceding 4 weeks. (There are 16 English-language versions of the HUI, differing in mode of administration ͓self vs. interviewer͔, assessment viewpoint ͓self-assessment vs. proxy͔, duration of health status assessment period ͓past 1-, 2-, or 3-weeks͔, and length of questionnaire ͓15vs. 40-item͔.) Individual health domain scores (single attribute scores) range from 0.00 (maximum impairment) to 1.00 (no impairment). Multiattribute (HUI index) scores, a multiplicative function of individual attribute levels, range from Ϫ0.03 to 1.00 for the HUI2 and Ϫ0.36 to 1.00 for the HUI3, with anchors 0.00 ϭ dead and 1.00 ϭ perfect health for both the HUI2 and HUI3. 4
Variables Used in Construct Validity Assessment Behavior
The California Dementia Behavior Questionnaire (CDBQ) is an 87-item caregiver survey for assessing behavioral disturbances in patients with dementia, with 6 caregiver mood items and 81 patient behavior items. 9 Twenty-two CDBQ items from the 3 CDBQ subscales judged a priori by the trial's steering committee to be the most important targets for the intervention comprised the behavior rating scale in the caregiver survey. The 3 CDBQ subscales, defined previously in an unpublished principal components analysis (Dan Mungas, PhD, personal communication May 19, 2008) , were the following: depression (9 items, coefficient ␣ ϭ 0.82), anger/ agitation (11 items, ␣ ϭ 0.77), and physical aggression (2 items, ␣ ϭ 0.92). Exploratory factor analysis of this abbreviated 22-item CDBQ with our patient sample confirmed the 3 factor structure: anger/agitation (eigenvalue 7.17; proportion variance explained ϭ 0.68; coefficient ␣ ϭ 0.90); depressed mood (eigenvalue 1.90; proportion variance explained ϭ 0.18; coefficient ␣ ϭ 0.82); physical aggression (eigenvalue 1.19; proportion variance explained ϭ 0.11; coefficient ␣ ϭ 0.80). Fourteen items assessed symptom frequency, and 8 items assessed severity over the preceding 4 weeks. Raw subscale scores were converted to a 0 to 100 possible range, with 0 ϭ most impaired and 100 ϭ least impaired (best) state.
Dementia Severity
The Blessed Dementia Rating Scale (BDRS) 10 is a widely used measure of dementia severity. The possible score range is 0 to 17, with higher scores indicating greater functional impairment. The coefficient ␣ for the BDRS in our sample was 0.90.
Medical Comorbidity
The Charlson Comorbidity Index (CCI) 11 is a measure of medical comorbidity. Prevalent medical conditions are assigned a weight from 1 to 6. A CCI score was calculated at baseline based on medical record abstraction assessing for medical conditions listed in the index. Higher scores indicate greater illness burden.
Global Status
Initial and follow-up surveys inquired about the patient's residential status: home, assisted living (AL), board and care (B and C), and skilled nursing facility (SNF). We posited that residential status was a reasonable proxy indicator of global dementia severity, 12 such that impairment was judged to be progressively worse across the residential levels in the following order: home, AL, B and C, and SNF.
Because the behavior scale yields continuous scores, we had to create categories defining "changed" and "unchanged" groups. Change categories were defined by first computing effect size (ES) statistics from behavioral scale change scores over the follow-up interval. ESs were then assigned ordinal change categories using Cohen's criteria: no change (ES Ͻ0.2), small change (0.2ՅES Ͻ0.5), medium change (0.5ՅES Ͻ0.8), or large change (ES Ն0.8). 13 Negative and positive ESs were grouped separately.
Residential change categories were unchanged (remained at home), and changed if the subject went from "home-to-SNF" between baseline and 12 months, or between baseline and 18 months. (Transitions to and from AL/B and C were excluded from this analysis because of the greater overlap in clinical status between patients in this group and those in the home and the SNF categories.)
Expert Panel Judgments of Responsiveness and Construct Validity Measures
We made a priori predictions of the magnitude of association between criterion variables and the HUI. We used a modified delta method 14 with a 3-person expert panel consisting of 2 board-certified geriatric psychiatrists and 1 board-certified neurologist. Panelists were provided with copies of the HUI, BDRS, CCI, and the behavior scale but did not have access to the results of data analyses.
For the construct validity analysis, panelists predicted magnitudes of correlations between HUI2/3 scores and the BDRS, CCI, and CDBQ. Ordinal categories for the magnitude of predicted correlation magnitudes were defined using Cohen's criteria 13 : 0 ϭ no correlation: r Ͻ 0.10 1 ϭ small correlation; 0.1 Յ r Ͻ 0.3 2 ϭ medium correlation; 0.3 Յ r Ͻ 0.5 3 ϭ large correlation; r Ն 0.5
The panel was also asked to predict the presence/ absence (1 ϭ presence/0 ϭ absence) of clinically meaningful differences in HRQOL (as indicated by mean HUI score) across residential levels (home, AL, B and C, SNF). Since the panel concluded that AL and B and C groups could not meaningfully be distinguished from each other, these groups were combined into the AL/B and C category.
For the responsiveness analyses, panelists predicted the magnitude of HUI2 and HUI3 ES statistics for all single attribute (except HUI2 fertility) and multiattribute scores in patients defined as having moderate change (improvement or worsening) on the behavior scale and subscales at 12-month follow-up. We assumed that the magnitude of the ES would be independent of the direction of change. Predictions of the ES associated with residential change categories (unchanged, home-to-SNF) were also elicited. Ordinal categories of ES magnitudes were defined using Cohen's criteria 13 Panelists made independent predictions of the correlations, the presence/absence of group differences in HUI2/3 across residential levels, and ES statistics described above, and results were tabulated. Disagreements between the experts were resolved via a single phone consensus meeting.
Statistical Analysis
Construct validity was assessed with Pearson correlations between behavior, dementia severity, and comorbidity scale scores and the HUI. Mean HUI scores were compared across residential groups with analyses of variance, using Duncan's multiple range test to identify significant pairwise differences.
Responsiveness was assessed with ES, standardized response mean, and Guyatt's statistic 15 across the behavior scale and residential status criterion variables at 12-and 18-month follow-up intervals.
We assessed the accuracy of expert panel predictions of construct validity and responsiveness measures using Cicchetti-Allison weighted statistics (using SAS software version 9.1). To compare the panel's ordinal scale predicted magnitudes of associations (scored from 0 to 3) with continuous values of observed correlations and ESs, the latter were converted to ordinal categories using Cohen's criteria. Since residential change was limited to decline, s for responsiveness results were computed only for subjects exhibiting decline. s for correlation and ES results were computed by comparing 16 pairs of predicted and observed results (8 HUI3 single attribute plus 1 multiattribute score; 6 HUI2 single attribute score; and 1 multiattribute score) for each external criterion measure (ie, BDRS, CCI, etc). s were also estimated to assess correspondence of observed data with predictions of presence/absence of significant group differences in HUI across residential levels (n ϭ 48 comparisons, reflecting 3 pairs of residential levels ͓ie, home vs. SNF ϫ 16 HUI predictions).
Following Landis and Koch, quality of agreement indicated by s was interpreted as follows: Ͻ 0.00, poor; ϭ 0.00 to 0.20, slight; ϭ 0.21 to 0.40, fair; ϭ 0.41 to 0.60, moderate; ϭ 0.61 to 0.80, substantial; and ϭ 0.81 to 1.00, almost perfect. 16 
RESULTS
Baseline Descriptive Statistics
The range of BDRS scores was 0 to 17, indicating that our sample comprised patients with all stages (mild, moderate, and severe) of dementia ( Table 1 ). The mean BDRS score of 5.9 (SD ϭ 3.7) is consistent with moderate dementia severity. 17 Mean multiattribute HUI2 and HUI3 scores were 0.54 (SD ϭ 0.23) and 0.17 (SD ϭ 0.31), respectively. By comparison, in a recent cross-sectional US population survey of noninstitutionalized persons, mean HUI2 scores were 0.85 in those aged 65 to 74 and 0.83 in those 75 to 89; corresponding mean HUI3 scores were 0.80 and 0.75, respectively. 18 The mean composite behavioral rating score in our sample was 85.0 (SD ϭ 14.1), reflecting mild-moderate levels of behavioral disturbance.
Convergent Validity
Cross-Sectional Correlations (r) With Dementia Severity, Behavior, and Comorbidity at Baseline
Correlations with the BDRS were large for the multiattribute HUI scores (r ϭ Ϫ0.69, P Յ 0.001 for both HUI2 and HUI3), and for HUI cognition, HUI2 self-care and mobility, and HUI3 ambulation attributes ( Table 2) . Correlations with the behavioral scale and subscales were generally moderate to large for HUI multiattribute (HUI2, 0.44; HUI3, 0.41; P Յ 0.001 for both), and emotion attribute scores and were larger for the HUI2 than the HUI3 emotion attribute (HUI2 range: 0.20-0.66; HUI3 range: 0.09-0.52). Correlations between HUI multiattribute scores and the CCI were small in magnitude but in the expected direction: HUI2, Ϫ0.12 (P Յ 0.01); HUI3, Ϫ0.10 (P Յ 0.01).
Cross-Sectional Mean Differences in HUI Scores Across Residential Levels
Both HUI2 and HUI3 index scores differed between the 3 residential levels, such that subjects living at home had the highest scores, B and C/AL subjects had intermediate scores, and patients in SNFs had the lowest scores (P Ͻ 0.05 for all pairwise comparisons). Scores on individual HUI attributes followed a similar pattern, but not all pairwise differences were significant. (These data are available from the corresponding author on request.) HUI2 and HUI3 single attribute scores were similar but multiattribute and cognition scores were larger in the HUI2 than the HUI3 (HUI2 multiattribute range across residential levels: 0.26 -0.51; HUI3 multiattribute range, Ϫ0.12 to 0.12; HUI2 cognition range, 0.26 -0.51; HUI3 cognition range, 0.21-0.33).
Responsiveness of HUI to Changes on the Behavioral Rating Scale
Since results were similar with all 3 responsiveness statistics (ES, standardized response mean, Guyatt's statistic) and between the 2 follow-up intervals (baseline to 12 months and 18 months, respectively), we report only ES results from baseline to 12 months (Table 3) Responsiveness of the HUI depended on the direction of change in the external scale. In patients with behavioral worsening, ESs were negative with magnitudes generally proportionate to magnitude of behavioral change. Although both HUI2 and HUI3 emotion attributes were especially responsive to behavioral worsening, ESs tended to be larger on the HUI2 than the HUI3. On the other hand, the sign and magnitude of HUI single and multiattribute score ESs did not reflect the improvements in behavior. In general, ESs in behaviorally improved subjects were either trivial or small and negative.
To better understand the unexpected HUI responsiveness results among subjects with improvement on the behavioral criterion measure, we conducted a post hoc analysis to explore the possibility that these results were being driven by the HUI's weighting scheme. We focused on the HUI emotion attribute as it was the HUI dimension most directly linked with the behavior scale items. We computed ESs for the HUI emotion attribute using unweighted HUI scores (ie, assuming equal distance between emotion attribute levels). The resulting ESs on the emotion attribute associated with small, medium, and large behavior improvements were 0.03, 0.46, and 0.28, respectively, for the HUI2, and 0.20, 0.05, and 0.19 for the HUI3; thus, all were small but were in the expected positive direction of change.
Responsiveness Using Change in Living Status as Global Change Criterion
ESs differed between subjects with no change in residence and those with change from home-to-SNF (Table 4 ). HUI2 ESs for the home-to-SNF group were generally medium to large (HUI2 multiattribute ES, Ϫ0.76), whereas HUI3 ESs were small to medium (HUI3 multiattribute ES, Ϫ0.50). In contrast, single and composite ESs for subjects remaining at home indicated insignificant or small change.
Comparison of Predicted and Observed Results
Weighted s comparing the expert panel's predicted versus observed results ranged from ϭ 0.55 to 0.61 for correlations between the HUI and both the behavioral scale and BDRS. s were lowest for predictions about HUI-CCI correlations ( ϭ 0.13) and for responsiveness results using the behavioral change criterion ( ϭ 0.16). For all other outcomes, s ranged from 0.30 to 0.55.
DISCUSSION
This study provides new evidence regarding the construct validity (including responsiveness) of the HUI in community-based subjects with dementia. We report 3 primary findings: (1) The HUI2 and HUI3 were responsive to graded clinical decline, and HUI2 was more responsive than the HUI3 to global clinical decline and behavioral deterioration.
(2) Responsiveness of the HUI was asymmetric, with good responsiveness to clinical worsening but poor responsiveness to improvement as defined by an external criterion of behavior change. (3) Support for the construct validity of the HUI in patients with dementia was found in associations with external indicators of HRQOL.
Responsiveness to Clinical Decline
Our study provides the first evidence of the HUI's responsiveness in subjects with dementia. Both the HUI2 and HUI3 were responsive to clinical worsening on a behavior rating scale. Effect sizes on the HUI2 and HUI3 emotion attributes were progressively larger negative values in subjects with small, medium, and large worsening on the behavior scale. Multiattribute ES values generally had a similar stepwise quality, but as composites of many other attributes, did not correspond as closely to behavioral change categories. Use of change in residential status as the external criterion provided evidence of the responsiveness of the HUI to global clinical worsening in patients with dementia. Notably, ES statistics tended to be greater in magnitude for the HUI2 than the HUI3. *n ϭ 392 to 408. Charlson Comorbidity Index score was based on medical record abstraction; higher scores indicate greater comorbidity burden. Blessed Dementia Rating Scale is scored 0 to 17, where higher scores mean more severe dementia. Composite behavior score, depressed mood, physical aggression and anger/agitation are scored 0 to 100, where 100 is best possible state. Health Utilities Index (HUI) single attribute scores range from 0.00 to 1.00 for both HUI2 and HUI3, where 1.00 is the best possible state. Multi-attribute (index) scores range from Ϫ0.03 to 1.00 on the HUI2 and from Ϫ0.36 to 1.00 on the HUI3, where 1.00 is the best possible state. † P Յ 0.001. ‡ P Յ 0.01. § P Յ 0.05. 
Asymmetry in Responsiveness Results
On the other hand, HUI responsiveness statistics in behaviorally improved patients did not reflect their improvement, even in the emotion attribute. In the large behavioral improvement group, ESs on the HUI2/3 emotion attributes were either insignificant or small and negative. Our findings thus suggest that in patients with dementia, the HUI may be differentially responsive to improvement and decline, with greater responsiveness to the latter. Asymmetry in an instrument's responsiveness has been previously reported and underscores the need for caution in pooling subjects with similar magnitudes but opposite direction of change in assessing responsiveness. 19 
Explaining the Asymmetric Responsiveness and Differences in HUI2/3 Responsiveness
The unexpected negative ESs in subjects with behavioral improvement resulted primarily from 2 factors: (1) differences in the "emotion" constructs captured by the HUI2, HUI3 and the behavior scale and (2) the HUI's preference weighting scheme.
The HUI2, HUI3, and the behavior scale capture different emotion constructs. The behavior rating scale consists of 22 questions, whereas the HUI2 and HUI3 both include only 1 emotion item. The behavior scale probes for a wider range of behavioral disturbances than the HUI2 and HUI3: namely, depressive verbalizations (ie, expressed suicidal ideation or concentration difficulties) and caregiver observations of anxiety, anger, agitation, mood lability, motor restlessness, paranoia, and aggression. Although the HUI2 emotion item assesses anger, agitation, anxiety, and irritability, the HUI3 emotion item only assesses levels of happiness/unhappiness, which are terms not included in the behavior scale. The behavior scale's greater overlap with HUI2 than with HUI3 content may explain the former's superior responsiveness to behavioral change. At the same time, the discrepancies between HUI emotion items and the behavioral scale questions may explain how subjects with net improvement on the latter were rated as worsened or unchanged on the HUI2/3.
Our post hoc analysis of responsiveness results demonstrated the role of the HUI's preference weighting system in producing the unexpected responsiveness findings among subjects improved on the behavior scale. Each level of an HUI attribute has a preference weight, reflecting its perceived value in HRQOL. Weights for the 5 levels of the HUI3 emotion attribute are the following: level 1, 1.00 (ie, perfect emotional health); 2, 0.91; 3, 0.73; 4, 0.33; and 5, 0.00. 20 When we computed ESs using equal spacing between levels (ie, 0, 0.25, 0.50, 0.75, 1.00), ESs were consistently positive in subjects with improvement, though magnitudes were smaller than expected. The role of weighting was suggested by the finding that among those with large improvement on the external scale, a much greater proportion improved on the HUI emotion items than worsened (35% vs. 14% on HUI2; 35% vs. 18% on HUI3). Extreme values did not account for the results since the proportion with large (Ն2 levels) improvement on the HUI emotion items was at least equal to the proportion with large worsening (10% vs. 2% for HUI2; 10% vs. 10% for HUI3). Rather, among those with behavioral improvement on the external scale, the subgroup with decline on the HUI emotion items experienced change between levels with a greater difference in weights than did those with improvement (difference between levels 3 and 4 is 0.40; between 4 and 5, 0.33; between 1 and 2, 0.09; and between 2 and 3, 0.18). To our knowledge, the impact of weighting on an instrument's responsiveness has not been reported previously and merits further study. With respect to our findings, it is possible that the HUI's general population weights do not reflect fully the health state valuations of persons with dementia or their caregivers.
Additional Evidence of HUI Construct Validity in Patients With Dementia
Our study provided additional evidence of the construct validity of the HUI in patients with dementia. Scores on the composite HUI2/3 were strongly correlated with clinical measures of dementia severity (BDRS) and moderately correlated with behavioral status (CDBQ). As with our responsiveness results, the HUI2 emotion attribute had a stronger association with the behavior scale than did the corresponding HUI3 attribute. Our finding that HRQOL differed across residential levels in the expected direction also supported the HUI's construct validity.
On the other hand, the magnitude of the correlation between scores on the CCI and the HUI was small, even though our panel had predicted stronger associations. The small variance of CCI scores was likely responsible for this negative result, though it is possible that the medical condi- *Health Utilities Index (HUI) single attribute scores range from 0.00 to 1.00 for both HUI2 and HUI3, where 1.00 is the best possible state. Multi-attribute (index) scores range from Ϫ0.03 to 1.00 on the HUI2 and from Ϫ0.36 to 1.00 on the HUI3, where 1.00 is the best possible state.
Kavirajan et al
Medical Care • Volume 47, Number 6, June 2009 tions (ie, hypertension) on the CCI are not significantly associated with HRQOL. 21 It is also possible that the weak correlations of the multiattribute HUI2/3 with the CCI and only moderate correlations of the HUI2/3 with the composite behavioral scale reflect limitations of the HUI2/3 in capturing important aspects of HRQOL in persons with dementia. In a qualitative study of patients with mild to moderate dementia and their caregivers, Silberfeld et al found that the HUI2/3 included only 8 of 56 items identified by patients and caregivers as important to quality of life in persons with dementia, 22 suggesting limitations of the content validity of HUI in patients with dementia.
Comparison of Study Results With Other Published Reports
Differences between our validity findings and those of Naglie et al 6 may have resulted from the narrower range of clinical variability in the Naglie et al's study, where patients had mild to moderate dementia and generally mild depression, whereas our sample included a broader spectrum of severity of dementia and of depression. It does not seem likely that the choice of informant on the HUI contributed to differences between our study and Naglie et al in associations between the HUI and measures of mood and behavior, since Naglie et al included proxy-rated as well as self-rated HUI scores. However, it is possible that differences in results were due to properties of the behavioral measures used in each study. Our behavioral rating scale included anger/agitation and physical aggression subscales and was completed by the caregiver, whereas the Geriatric Depression Scale used by Naglie et al focused on depression and was completed by the patient. 6 Our results are consistent with those of Neumann et al, who found similar graduated differences in HUI scores dementia severity levels defined using an established clinical dementia rating scale. 5 HUI2 and HUI3 multiattribute score ranges in our subjects correspond to those reported by Neumann et al among patients with moderate to profound dementia (HUI2 multiattribute range, 0.53-0.27; HUI3 multiattribute score range, 0.19 --0.08). The discrepancy between HUI2 and HUI3 scores in both Neumann et al and our study is noteworthy. Neumann et al found that 60% of the difference between HUI3 and HUI2 scores could be attributed to differences in weighting of states worse than death. The lowest possible multiattribute HUI3 score is Ϫ0.36 as compared with Ϫ0.03 on the HUI2, and Neumann et al found that differences between HUI2 and HUI3 scores were greatest in patients with more advanced dementia. The differences in QOL scores between the HUI2 and HUI3 highlight the need for caution in comparing QOL assessments using different generic HRQOL instruments, and support the use of multiple HRQOL measures in cost-effectiveness studies. Comparative studies of generic HRQOL measures across the general population 18 and among specific patient groups 6, 23 have likewise found significant differences in HRQOL ratings of the same health state with different instruments. Most important in cost-effectiveness studies, though, is whether HRQOL change estimates differ significantly between measures. Differences in change scores between different HRQOL measures requires further study. 23 The magnitude of multiattribute HUI2 and HUI3 ESs (Ϫ0.48 for both) observed in patients with small behavioral worsening are consistent with the ESs observed in responsiveness studies of other QOL instruments corresponding to small but clinically important differences. In a review of the literature on minimally important differences (MID) in HRQOL measures, Norman et al found that mean ES on QOL measures corresponding to a small clinically meaningful change was 0.495 (SD ϭ 0.155). 24 Reflecting the larger clinical change associated with change in residence from home to SNF, the corresponding ES on the HUI2 was Ϫ0.76 but was only Ϫ0.50 on the HUI3. Even smaller ES are likely to be clinically meaningful. 25 
Implications of Responsiveness and Validity Results
Our findings have significant implications for analyses using the HUI in patients with dementia. First, both the HUI2 and HUI3 are responsive to grades of clinical deterioration and may offer important information regarding the utility of treatments that slow decline. Second, the HUI's poor responsiveness to behavioral improvement may result in underestimation of the utility of effective psychiatric interventions in subjects with dementia. Third, because of its greater sensitivity to a range of behavioral disturbances and inclusion of a self-care attribute with good validity and responsiveness, the HUI2 may be preferable to the HUI3 in cost-utility analyses studies in patients with dementia.
Strengths of Study Design
A particular strength of this study was the use of a formal method to generate a priori predictions about associations for our analysis of construct validity. In general, weighted kappa statistics indicated fair to moderate agreement ( ϭ 0.30 -0.55) between predicted and observed results. Predictions were least accurate ( Ͻ 0.20) for HUI-CCI scale correlations and for ES using the behavioral scale anchor. In the former case, as noted above, limited variance in CCI scores together with a floor effect produced unexpectedly modest correlations with the HUI, and the panel consistently overestimated the correlation. With the ES results using the behavioral anchor, predictions were based on the expected relationship between HUI and the behavioral scale items, but did not take into account the natural global decline in this group of patients with dementia. Thus, most mismatches between predicted and observed results in these responsiveness results resulted from subjects experiencing decline in attributes without an evident conceptual link with the behavioral scale items.
Our study has several additional strengths. We used well-accepted assessment instruments of dementia severity and medical comorbidity in the construct validity assessment. Multiple external indicators, namely the BDRS, CCI, behavioral scale and residential status, reflecting different aspects of dementia health status, were used to assess construct validity. Responsiveness was assessed using behavioral and global status measures, which, together with caregiver factors, are the most important indicators of HRQOL in patients with dementia. 5, 26, 27 Also, our study has good external validity as the sample consisted of community-based elders enrolled from all diagnosed dementia patients from 3 large medical practice groups.
Limitations of our Study
We used an abbreviated behavior scale and a proxy measure of global status, but ideally assessment of instrument validity would have included additional external measures of important aspects of dementia, including a global rating and a more extensive behavioral assessment scale. 19 Although available evidence supports the use of residential status as a proxy for global dementia severity, 12 we note that considerable overlap in dementia levels exists in patients across residential levels. In addition, although support for the testretest reliability of the proxy-administered HUI3 in patients with mild to moderate dementia has been reported, 6 reliability of caregiver-rated HUI2/3 scores in moderate to severe dementia has not been well established.
The use of proxy informants must be considered in interpreting our findings. Reliability of proxies in assessment of QOL in advanced stages of dementia has not been established. Proxies tend to indicate greater impairment in QOL than do dementia patients in their self-report. 27 Discrepancies between patient and proxy ratings are greater in more advanced dementia and in the more subjective HRQOL domains such as emotional status and pain. Also, evidence suggests that proxy ratings may be influenced by degree of relatedness to the patient. 28 Nevertheless, as a practical matter, the unreliability and inaccuracy of self-report in patients with moderate to severe dementia necessitate use of proxy informants in HRQOL assessment with this patient population. 29 Although our study supports the construct validity of the proxy-rated HUI2/3 in patients with mild through severe dementia, further studies are needed to assess the validity (including responsiveness) of the self-rated HUI in subjects with mild to moderate dementia, for whom self-assessment may be feasible. Direct comparison of the reliability, validity, and agreement of proxy and self-reported HUI in patients with a range of dementia grades may help investigators to determine which HUI version (self vs. proxy) to use for which dementia level.
As with the HUI, our dementia rating instrument (BDRS) relied upon caregiver report of the patient's functional status rather than direct memory assessment. Available evidence, however, including the original paper by Blessed et al 10 as well as more recent work by Jorm, 30 indicates that informant-based assessments may better reflect dementia status than direct memory assessment in nonclinical settings.
Finally, our assessments of construct validity and responsiveness assumed linear relationships between HRQOL and behavioral symptoms, dementia severity, and comorbidity, but in some chronic medical conditions, such as stroke and congestive heart disease, nonlinear models may better reflect the relationship between HRQOL and disease severity. 31 
CONCLUSION
In summary, we have demonstrated good responsiveness of the caregiver-rated HUI to graded behavioral and global decline but poor responsiveness to improvement among patients with a wide range of dementia severity, including patients with moderate to severe dementia. Notably, the HUI2 may be more responsive to behavioral worsening and global decline than the HUI3 in patients with dementia. In addition, with 2 prior reports offering conflicting evidence regarding the validity of the HUI in subjects with dementia, 5, 6 this study provides additional support for the construct validity of the HUI as an HRQOL measure in patients with dementia. Additional studies of validity using multiple external criteria are needed to further gauge the validity, including responsiveness, of the HUI in patients with different grades of dementia, with particular emphasis on the role of weighting and choice of informant (self vs. proxy). In the meantime, since responsiveness of HRQOL measures in patients with dementia is not well-established, we recommend that researchers use multiple generic and diseasespecific HRQOL measures in dementia trials to confirm the robustness of results using the HUI2/3. Investigators should use the proxy-rated HUI in persons with moderate to severe dementia, but it is possible that self-reported HUI may be appropriate in subjects with milder cognitive impairment.
